Status:

COMPLETED

Plasmodium Resistance in A. Gambiae

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Malaria

Plasmodium Falciparum Malaria

Eligibility:

All Genders

5-10 years

Brief Summary

The purpose of this study is to find new ways to control malaria by looking at mosquitoes infected with the disease. Knowledge of the genetics that affect the spread of malaria by mosquitoes will help...

Detailed Description

Malaria is a blood-borne human disease, and is transmitted to mosquitoes in the bloodmeal, an obligatory step in human malaria transmission. This is a study of malaria parasites in the major mosquito ...

Eligibility Criteria

Inclusion

  • Age 5-10 years old
  • No major diagnosable health problems (compared to local population)
  • Willing to participate in the study
  • Identified as having a malaria infection by blood film examination

Exclusion

  • Outside the inclusion age group
  • Specific major diagnosable health problems
  • Not willing to participate in the study

Key Trial Info

Start Date :

June 1 2007

Trial Type :

OBSERVATIONAL

End Date :

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00466557

Start Date

June 1 2007

Last Update

January 31 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre National de Recherche et de Formation sur le Paludisme

West Africa, Burkina Faso

Plasmodium Resistance in A. Gambiae | DecenTrialz